S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avinger, Inc. stock logo
AVGR
Avinger
$3.70
+2.2%
$3.35
$2.50
$18.00
$5.88M1.2648,834 shs6,085 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.59
+5.4%
$0.46
$0.37
$1.62
$2.86M0.45383,135 shs1.40 million shs
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
$0.00
$0.00
$0.01
N/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$0.04
+36.6%
$0.10
$0.02
$2.19
$846K1.4614.47 million shs486.23 million shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avinger, Inc. stock logo
AVGR
Avinger
+2.21%-0.54%+27.59%+38.06%-60.85%
Dynatronics Co. stock logo
DYNT
Dynatronics
+6.36%+46.29%+35.70%+4.48%-58.54%
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
0.00%0.00%0.00%0.00%-98.00%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
+62.88%+50.40%-70.70%-87.48%-98.14%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avinger, Inc. stock logo
AVGR
Avinger
2.3819 of 5 stars
3.55.00.00.02.50.00.6
Dynatronics Co. stock logo
DYNT
Dynatronics
2.0366 of 5 stars
3.05.00.00.03.10.00.6
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avinger, Inc. stock logo
AVGR
Avinger
3.00
Buy$5.0035.14% Upside
Dynatronics Co. stock logo
DYNT
Dynatronics
2.00
Hold$3.80549.57% Upside
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
N/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.00
HoldN/AN/A

Current Analyst Ratings

Latest AVGR, SINT, DYNT, and MDIT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/21/2024
Avinger, Inc. stock logo
AVGR
Avinger
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00
2/5/2024
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avinger, Inc. stock logo
AVGR
Avinger
$7.65M0.77N/AN/A($4.53) per share-0.82
Dynatronics Co. stock logo
DYNT
Dynatronics
$35.18M0.08N/AN/A$2.19 per share0.27
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
N/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$2.63M0.32N/AN/A$1.65 per share0.02

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avinger, Inc. stock logo
AVGR
Avinger
-$18.32M-$26.34N/AN/AN/A-239.41%N/A-106.16%5/8/2024 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$4.97M-$1.38N/AN/A-14.13%-54.88%-16.14%5/9/2024 (Estimated)
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$8.26M-$3.42N/AN/A-314.39%-67.12%-45.49%5/20/2024 (Estimated)

Latest AVGR, SINT, DYNT, and MDIT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/20/2024Q4 2023
Avinger, Inc. stock logo
AVGR
Avinger
$0.64-$3.93-$4.57-$3.93$2.52 million$1.91 million
2/7/2024Q2 2024
Dynatronics Co. stock logo
DYNT
Dynatronics
N/A-$0.27-$0.27-$0.27N/A$8.15 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avinger, Inc. stock logo
AVGR
Avinger
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avinger, Inc. stock logo
AVGR
Avinger
N/A
0.63
0.36
Dynatronics Co. stock logo
DYNT
Dynatronics
0.21
1.41
0.67
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
N/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
1.90
1.60

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avinger, Inc. stock logo
AVGR
Avinger
18.30%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%

Insider Ownership

CompanyInsider Ownership
Avinger, Inc. stock logo
AVGR
Avinger
4.29%
Dynatronics Co. stock logo
DYNT
Dynatronics
9.10%
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
85.40%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
0.79%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avinger, Inc. stock logo
AVGR
Avinger
681.59 million1.52 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
1544.88 million4.44 millionNot Optionable
Medite Cancer Diagnostics, Inc. stock logo
MDIT
Medite Cancer Diagnostics
69N/AN/ANot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
4122.68 million22.50 millionNot Optionable

AVGR, SINT, DYNT, and MDIT Headlines

SourceHeadline
Why SINTX Technologies Stock Is Getting HammeredWhy SINTX Technologies Stock Is Getting Hammered
msn.com - April 3 at 2:48 PM
SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock
globenewswire.com - April 3 at 9:00 AM
Why SINTX Technologies Stock Hit A New All-Time Low TodayWhy SINTX Technologies Stock Hit A New All-Time Low Today
msn.com - April 1 at 3:51 PM
DDC Appoints Vice President to Drive Operational ExcellenceDDC Appoints Vice President to Drive Operational Excellence
itnewsonline.com - March 30 at 6:23 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 29 at 4:00 PM
SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023
investorplace.com - March 28 at 7:02 AM
Sintx Technologies Prices Public Offering Of $1.3 Mln Of SharesSintx Technologies Prices Public Offering Of $1.3 Mln Of Shares
markets.businessinsider.com - March 25 at 1:22 PM
Why SINTX Technologies Stock Is Down 50%Why SINTX Technologies Stock Is Down 50%
msn.com - March 25 at 1:22 PM
Why Is Sintx Technologies (SINT) Stock Down 31% Today?Why Is Sintx Technologies (SINT) Stock Down 31% Today?
investorplace.com - March 25 at 9:05 AM
SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common StockSINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock
globenewswire.com - March 25 at 9:00 AM
US Stocks Edge Lower; FedEx Posts Upbeat EarningsUS Stocks Edge Lower; FedEx Posts Upbeat Earnings
msn.com - March 23 at 3:15 AM
Why SINTX Technologies Is Trading Higher TodayWhy SINTX Technologies Is Trading Higher Today
aol.com - March 22 at 10:14 PM
Gold Moves Lower; Lululemon Shares PlummetGold Moves Lower; Lululemon Shares Plummet
msn.com - March 22 at 5:14 PM
Dow Dips 200 Points; Nike Shares Fall After Q3 ResultsDow Dips 200 Points; Nike Shares Fall After Q3 Results
markets.businessinsider.com - March 22 at 5:14 PM
SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%SINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%
markets.businessinsider.com - March 22 at 5:14 PM
Why SINTX Technologies Stock Is NosedivingWhy SINTX Technologies Stock Is Nosediving
msn.com - March 22 at 5:14 PM
SINTX Technologies Announces Proposed Public Offering of Common StockSINTX Technologies Announces Proposed Public Offering of Common Stock
globenewswire.com - March 22 at 8:30 AM
Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20Sintx Technologies (SINT) Price Target Increased by 42.86% to 10.20
msn.com - February 24 at 2:14 PM
Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)
benzinga.com - February 23 at 7:50 AM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
finance.yahoo.com - February 21 at 3:58 PM
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
globenewswire.com - February 21 at 9:00 AM
SINTX Technologies: Other EventsSINTX Technologies: Other Events
cbonds.com - February 16 at 10:37 AM
SINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturingSINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturing
tctmagazine.com - February 7 at 10:57 AM
Sintx Technologies just downgraded at Maxim, heres whySintx Technologies just downgraded at Maxim, here's why
realmoney.thestreet.com - February 5 at 5:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Avinger logo

Avinger

NASDAQ:AVGR
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.
Dynatronics logo

Dynatronics

NASDAQ:DYNT
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Medite Cancer Diagnostics logo

Medite Cancer Diagnostics

OTCMKTS:MDIT
Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning. It also provides M630, a freezing microtome; TST44, a robotic multi-staining system; COT 20, a linear staining system; and RCM 9000, ACS 720, and TWISTER robotic coverslippers. In addition, the company develops SoftKit device for the self-collection of a sample that can be evaluated to provide an assessment of the health of the entire female genital tract. It sells its products through direct sales and distributors in the United States, China, Europe, and North Africa. The company serves histology and cytology laboratories associated with hospitals or research institutions, and independent laboratories. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida.
Sintx Technologies logo

Sintx Technologies

NASDAQ:SINT
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.